• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

diabetes mellitus

Kerendia: New Drug for Diabetic Kidney Disease
Posted inMetabolism, New Drugs, Regulatory

Kerendia: New Drug for Diabetic Kidney Disease

February 16, 2022September 8, 2022

Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.

Precigen ActoBio: Innovative Treatment for Type 1 Diabetes Mellitus
Posted inAutoimmune Diseases, Clinical Trials, Metabolism

Precigen ActoBio: Innovative Treatment for Type 1 Diabetes Mellitus

June 11, 2021September 8, 2022

The autoimmune disease will be defeated by restoring immune tolerance.

obesity
Posted inMetabolism, New Drugs, Regulatory

Wegovy: Most Effective Drug for Weight Loss

June 9, 2021September 8, 2022

Semaglutide can help you lose 15% of your excess weight in a year. And even more.

Lybalvi: New Drug for Schizophrenia and Bipolar I Disorder
Posted inNeuroscience, New Drugs, Regulatory

Lybalvi: New Drug for Schizophrenia and Bipolar I Disorder

June 3, 2021September 8, 2022

Combination of olanzapine and samidorphan will prevent unwanted weight gain in patients.

Liver.
Posted inMetabolism, New Drugs, Regulatory

Lipaglyn: World’s First Drug to Treat Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease

April 6, 2021September 8, 2022

Saroglitazar by Zydus Cadila has opened the doors to a new multi-billion dollar sector of NASH and NAFLD pharmacological treatments.

Posts navigation

Newer posts 1 2
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News